Skip to content

Surgery Partners, Inc. SGRY Other Nonrecurring Income Expense

Other Nonrecurring Income Expense at other companies

Vertex, Inc. logo
Vertex, Inc.VERX
$3.25M-0.4%
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
-$1.7M
Pitney Bowes logo
Pitney BowesPBI
$0-100%
PVH logo
PVHPVH
$0
SBA Communications logo
SBA CommunicationsSBAC
$22.52M-30.0%
Celanese Corporation logo
Celanese CorporationCE
$20M-35.5%

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.99B-49.1%

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonrecurringIncomeExpense.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s other nonrecurring income expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s other nonrecurring income expense?
Surgery Partners, Inc. (SGRY) reported other nonrecurring income expense of -$1.7M in Q1 2026.
What is the long-term trend for Surgery Partners, Inc.'s other nonrecurring income expense?
Over 4 years (2021 to 2025), Surgery Partners, Inc.'s other nonrecurring income expense has grown at a -13.4% compound annual growth rate (CAGR), from -$15.5M to -$8.7M.
What does other nonrecurring income expense mean?
Includes miscellaneous income or expenses that are not part of the company's core recurring operations, such as one-time adjustments or non-operating gains. Tracking this helps investors isolate the underlying performance of the business from transient financial events.